144 related articles for article (PubMed ID: 7610352)
1. Laboratory markers of colonoscopic activity in ulcerative colitis and Crohn's colitis.
Moran A; Jones A; Asquith P
Scand J Gastroenterol; 1995 Apr; 30(4):356-60. PubMed ID: 7610352
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease.
Jusué V; Chaparro M; Gisbert JP
Dig Liver Dis; 2018 Apr; 50(4):353-359. PubMed ID: 29396129
[TBL] [Abstract][Full Text] [Related]
3. Surrogate Markers of Intestinal Inflammation in Paediatric Patients with Inflammatory Bowel Disease.
Shentova R; Baycheva M; Kofinova D; Hadjiiski P; Yaneva P
Folia Med (Plovdiv); 2020 Jun; 62(2):271-275. PubMed ID: 32666743
[TBL] [Abstract][Full Text] [Related]
4. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
Cellier C; Sahmoud T; Froguel E; Adenis A; Belaiche J; Bretagne JF; Florent C; Bouvry M; Mary JY; Modigliani R
Gut; 1994 Feb; 35(2):231-5. PubMed ID: 7508411
[TBL] [Abstract][Full Text] [Related]
5. Plasma viscosity in inflammatory bowel disease.
Lobo AJ; Jones SC; Juby LD; Axon AT
J Clin Pathol; 1992 Jan; 45(1):54-7. PubMed ID: 1740516
[TBL] [Abstract][Full Text] [Related]
6. Faecal clearance of alpha 1-antitrypsin reflects disease activity and correlates with rapid turnover proteins in chronic inflammatory bowel disease.
Miura S; Yoshioka M; Tanaka S; Serizawa H; Tashiro H; Asakura H; Tsuchiya M
J Gastroenterol Hepatol; 1991; 6(1):49-52. PubMed ID: 1909193
[TBL] [Abstract][Full Text] [Related]
7. Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease.
Reinisch W; Heider KH; Oberhuber G; Dejaco C; Müllner M; Adolf GR; Gasché C
Gut; 1998 Sep; 43(3):375-82. PubMed ID: 9863483
[TBL] [Abstract][Full Text] [Related]
8. Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity.
Meyers S; Wolke A; Field SP; Feuer EJ; Johnson JW; Janowitz HD
Gastroenterology; 1985 Jul; 89(1):13-8. PubMed ID: 3874110
[TBL] [Abstract][Full Text] [Related]
9. Laboratory assessment of disease activity in childhood Crohn's disease and ulcerative colitis.
Macfarlane PI; Miller V; Wells F; Richards B
J Pediatr Gastroenterol Nutr; 1986 Jan; 5(1):93-6. PubMed ID: 3944748
[TBL] [Abstract][Full Text] [Related]
10. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
[TBL] [Abstract][Full Text] [Related]
11. [Initial clinical experiences with a simplified analytic method for fecal alpha-1-antitrypsin].
Fischbach W; Deubel M; Boege F; Mössner J
Z Gastroenterol; 1991 Dec; 29(12):650-4. PubMed ID: 1771947
[TBL] [Abstract][Full Text] [Related]
12. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
López Morante AJ; Sáez-Royuela F; Yuguero del Moral L; Martín Lorente JL; Ojeda Giménez C
Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
[TBL] [Abstract][Full Text] [Related]
13. [Serum acute phase proteins for determining disease activity of ulcerative colitis and Crohn disease].
Vucelić B; Milicić D; Krznarić Z; Korać B; Sentić M; Hadzić N; Stavljenić A; Cvorisćec D
Acta Med Austriaca; 1991; 18(4):100-5. PubMed ID: 1722373
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
Niederau C; Backmerhoff F; Schumacher B; Niederau C
Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
[TBL] [Abstract][Full Text] [Related]
15. Individual fecal alpha 1-antitrypsin excretion reflects clinical activity in Crohn's disease but not in ulcerative colitis.
Becker K; Berger M; Niederau C; Frieling T
Hepatogastroenterology; 1999; 46(28):2309-14. PubMed ID: 10521988
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
17. Serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease of different disease activities.
Philipsen EK; Bondesen S; Andersen J; Larsen S
Scand J Gastroenterol; 1995 Jan; 30(1):50-3. PubMed ID: 7701250
[TBL] [Abstract][Full Text] [Related]
18. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease.
Gomes P; du Boulay C; Smith CL; Holdstock G
Gut; 1986 Jan; 27(1):92-5. PubMed ID: 3949241
[TBL] [Abstract][Full Text] [Related]
19. Fecal Human Neutrophil Peptide Levels Correlate with Intestinal Inflammation in Ulcerative Colitis.
Kanmura S; Hamamoto H; Morinaga Y; Oda K; Fujita T; Arima S; Nasu Y; Sasaki F; Hashimoto S; Taguchi H; Setoyama H; Ido A
Digestion; 2016; 93(4):300-8. PubMed ID: 27220673
[TBL] [Abstract][Full Text] [Related]
20. Differing acute phase responses in Crohn's disease and ulcerative colitis.
Saverymuttu SH; Hodgson HJ; Chadwick VS; Pepys MB
Gut; 1986 Jul; 27(7):809-13. PubMed ID: 3732890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
